Inoue, Akitoshi http://orcid.org/0000-0002-8610-2571
Sheedy, Shannon P. http://orcid.org/0000-0002-7712-8278
Wells, Michael L. http://orcid.org/0000-0001-9411-6087
Mileto, Achille http://orcid.org/0000-0002-6341-7837
Goenka, Ajit H. http://orcid.org/0000-0002-7804-2695
Ehman, Eric C. http://orcid.org/0000-0003-4613-7101
Yalon, Mariana http://orcid.org/0000-0001-7032-4068
Murthy, Naveen S. http://orcid.org/0000-0002-2658-8864
Mathis, Kellie L. http://orcid.org/0000-0002-2547-5606
Behm, Kevin T. http://orcid.org/0000-0003-2021-9424
Shawki, Sherief F. http://orcid.org/0000-0003-4065-890X
Bruining, David H. http://orcid.org/0000-0003-4320-8429
Graham, Rondell P. http://orcid.org/0000-0002-8686-4867
Fletcher, Joel G. http://orcid.org/0000-0002-8941-5434
Article History
Received: 27 August 2022
Revised: 4 November 2022
Accepted: 8 November 2022
First Online: 4 February 2023
Declarations
:
: Achille Mileto—Consultant for Bayer Healthcare. Ajit H. Goenka— Others: Research grant from the Champions for Hope Pancreatic Cancer Research Program of the Funk-Zitiello Foundation; Advance the Practice Award from the Department of Radiology, Mayo Clinic, Rochester, Minnesota; CA190188, Department of Defense (DoD), Office of the Congressionally Directed Medical Research Programs (CDMRP); R01CA256969, National Cancer Institute (NCI) of the National Institutes of Health (NIH); Institutional research grant from Sofie Biosciences; Advisory Board (ad hoc), BlueStar Genomics. David H. Bruining– Consulting: Medtronics and Janssen; Research support: Medtronics and Takeda; Helmsley Charitable Trust (grants to institution). Joel G. Fletcher—Siemens Healthcare GmbH (grant to institution); Helmsley Charitable Trust (grants to institution); Pfizer (grant to institution); Boehringer Ingelheim (consulting to institution); Takeda (consulting to institution); Janssen (consulting to institution); Glaxo Smith Kline (consulting to institution). For the remaining authors – none were declared.